Phase II study of weekly intravenous menogaril in the treatment of recurrent astrocytomas in adults

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Neuro-Oncology

• Publication date

  1992-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00172769PMID 1331346
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Menogaril: a new anthracycline agent entering clinical trials

  2004influential reference
• Phase I study of oral menogaril administered on a once weekly schedule

  1990cited by this paper
• Phase I Study of Weekly Intravenous Administration of Menogaril to Adults with Solid Tumors

  1989cited by this paper
• The role of chemotherapy in the treatment of gliomas in adults.

  1989cited by this paper
• Human Central Nervous System Pharmacology of Antineoplastic Agents: Implications for the Treatment of Brain Tumors

  1987cited by this paper
• Intraarterial Chemotherapy for Brain Tumors: A Summary of the Ottawa Experience

  1987cited by this paper
• Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.

  1986cited by this paper
• Evaluation of malignant glioma patients during the postirradiation period.

  1979cited by this paper
• Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors.

  1977cited by this paper

• New agents in the treatment of primary brain tumors

  2005cites this paper
• Human autopsy-tissue distribution of menogaril and its metabolites

  2004cites this paper
• Recent developments in the field of antitumour anthracyclines.

  2001cites this paper
• Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives

  1999cites this paper
• Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide

  1999cites this paper
• MST-16, a novel derivative of bis(2,6-dioxopiperazine), synergistically enhances the antitumor effects of anthracyclines

  1998cites this paper
• The role of chemotherapy in recurrent malignant gliomas: an overview.

  1996cites this paper